跳至主要内容
临床试验/IRCT20140208016529N3
IRCT20140208016529N3已完成3 期

The effect of Sour tea supplementation on liver enzymes, total antioxidant capacity, glycemic indicator, lipid profile and sonographic outcomes in patients with nonalcoholic fatty liver disease:A randomized controlled trial.

Esfahan University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
23 years 至 55 years(—)
性别
All

入选标准

  • Patients with the nonalcoholic fatty liver disease confirmed with imaging techniques.
  • Body Mass Index (BMI) of them is greater than 24.9 and lower than 40.

排除标准

  • Alcohol consumption
  • Pregnant and lactating women
  • Any known forms of hepatic or metabolic disease except NAFLD, such as hereditary hemochromatosis, Wilson’s disease, cirosis, other metabolic disease
  • history of gastric bypass or intestine surgery
  • Taking hepatotoxic drugs such as calcium channel blocker, methotrexate, amiodarone, chloroquine and anti inflammatory drugs
  • Using antioxidant supplements
  • Hormone Therapy
  • Patients with a history of Cushing’s syndrome
  • renal failure
  • Participants with less than 80% are going to be excluded.

研究者

相似试验